STOCK TITAN

Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Rain Oncology Inc. (NasdaqGS: RAIN) will report Q2 2023 financial results and provide a corporate update on August 10, 2023. The management will host a conference call and webcast to discuss business and financial results. Dial-in numbers and webcast link provided.
Positive
  • None.
Negative
  • None.

NEWARK, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”) today announced it will report financial results for the second quarter ended June 30, 2023 and provide a corporate update on Thursday, August 10, 2023. On that day, management will host a conference call and webcast at 2:00 pm PT (5:00 pm ET) to discuss the Company’s business and financial results.

Conference Call and Webcast Details:
Date: August 10, 2023
Time: 2:00 pm PT (5:00 pm ET)
Dial In Numbers: 1 (888) 886-7786 (U.S. Toll Free) / 1 (416) 764-8658 (International)
Conference ID: 29873479
Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=1624922&tp_key=7933f8175f

A replay of the call will be available by visiting the "Events" section of the Rain website after the conclusion of the presentation and will be archived on the Rain website for 30 days.

About Rain Oncology Inc.
Rain Oncology Inc. is a precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit. Rain’s lead product candidate, milademetan, is a small molecule, oral inhibitor of MDM2-p53 complex that reactivates p53.

Media Contact
Mahima Agochiya
Rain Oncology
magochiya@rainoncology.com        

Investor Contact
Dan Ferry
LifeSci Advisors
+1.617.430.7576
daniel@lifesciadvisors.com


Rain Oncology Inc. will report financial results for the second quarter ended June 30, 2023 on August 10, 2023.

You can access the conference call and webcast through the provided webcast link: https://viavid.webcasts.com/starthere.jsp?ei=1624922&tp_key=7933f8175f

The replay of the call will be available by visiting the 'Events' section of the Rain website after the presentation and will be archived on the Rain website for 30 days.
Rain Oncology Inc

NASDAQ:RAIN

RAIN Rankings

RAIN Latest News

RAIN Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Link

About RAIN

rain therapeutics is a san francisco bay area-based biotechnology company, focused on developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic driver.